查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1403437

到 2030 年可穿戴注射器市场预测：按类型、使用类型、技术、应用、最终用户和地区进行的全球分析

Wearable Injectors Market Forecasts to 2030 - Global Analysis By Type, By Usage Type, Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2023 年全球穿戴式註射器市场规模为 90.1 亿美元，预计在预测期内将以 11.9% 的复合年增长率成长，到 2030 年达到 198 亿美元。

穿戴式註射器是穿戴在身体上的紧凑型医疗设备，有助于受控和一致的药物输送。这些设备透过皮下输送药物，为慢性病患者提供方便和精确的剂量。它们有多种形式，通常包含电子或机械系统，允许个体化治疗计划以及长时间连续或间歇性输送药物。

据国际糖尿病联盟称，到 2045 年，预计将有超过 7.8 亿人患有糖尿病。

慢性病增加

随着糖尿病、心血管疾病、自体免疫疾病等盛行率的不断上升，对便捷、准确的给药方式的需求日益增长。穿戴式註射器提供了一种解决方案，为患者提供了一种自我给药的方法，确保剂量一致并提高治疗医嘱遵从性。它为慢性病提供长期治疗的能力正在推动市场成长，因为它满足了患者增加便利性和有效管理持续健康挑战的需求。

与穿戴式註射器相关的成本

与穿戴式註射器相关的成本因素是市场的一个重大抑制因素。由于技术先进、製造复杂性和专用材料，这些设备通常成本较高。这种高成本限制了一些患者的使用并影响了普及。此外，报销挑战和医疗保健预算限制也阻碍了普及。

医疗基础设施和文明病的增加

随着医疗保健系统的发展，人们越来越重视以病人为中心的护理和创新的药物输送方法。穿戴式註射器顺应了这一趋势，提供了一种易于使用、自我管理的方法来管理现代生活方式中普遍存在的慢性疾病。这种融合为穿戴式註射器创造了机会，可以满足慢性病患者的需求，并提供高效、便利的药物输送解决方案，从而推动穿戴式註射器的采用和市场成长。

倾向于替代药物传输系统

虽然患者和医疗保健提供者探索口服药物和传统注射等多种选择，但穿戴式註射器的趋势对市场成长构成了挑战。病患偏好、成本考量以及竞争科技的发展等因素阻碍了穿戴式註射器的采用。这种趋势可能会阻碍穿戴式註射器的普及，影响市场渗透率，并减缓预期的市场扩张，儘管它们具有准确和方便的药物传输优势。

COVID-19 的影响：

COVID-19 大流行对穿戴式註射器市场产生了重大影响。选择性手术的延迟、患者就诊的减少以及财务限制暂时减缓了可穿戴注射器的采用。然而，疫情凸显了对远距医疗解决方案的需求，随着患者在医疗保健中断的情况下寻求方便的家庭治疗选择，推动了对穿戴式註射器的长期兴趣和创新。这是有可能的。

预计糖尿病领域在预测期内将是最大的领域。

穿戴式註射器市场由糖尿病领域主导。随着世界各地糖尿病盛行率的增加，对高效、便利的药物传输系统的需求不断增长。穿戴式註射器为糖尿病患者提供了一种管理胰岛素剂量的便利方法，确保准确剂量并提高治疗医嘱遵从性。此外，技术进步和专为糖尿病管理量身定制的用户友好型整合系统的开拓进一步增强了该领域在市场上的主导地位。

预计离体注射器细分市场在预测期内复合年增长率最高

由于设备的便携性和弹性，离体注射器市场预计将出现显着增长，这些设备允许用户携带和方便地给药，而不受佩戴在身上的限制。更谨慎和更易于使用的药物输送方法的趋势，特别是对于需要间歇给药或长期治疗的治疗，正在推动对外部注射器的需求。此外，与各种药物的兼容性以及适应不同患者偏好的能力也有助于穿戴式註射器市场的扩大。

比最大的地区

由于先进的医疗基础设施、慢性病的高盛行率以及精通技术的人口的结合，北美预计将主导可穿戴注射器市场。该地区强大的法规环境支持创新医疗技术的采用。不断增长的医疗保健支出和主要市场参与者的存在进一步增强了北美的领导地位。

复合年增长率最高的地区：

由于人口不断增长、慢性病患病率上升以及医疗保健意识不断增强，预计亚太地区可穿戴注射器市场将显着增长。在中国、印度和日本等国家，积极的政府措施、改善的医疗基础设施以及更多地采用创新技术正在促进市场扩张。此外，亚太地区可支配收入的增加以及向以患者为中心的医疗保健模式的转变进一步推动了亚太地区可穿戴注射器的成长。

提供免费客製化：

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 调查来源
    • 主要调查来源
    • 二次调查来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 技术分析
  • 应用分析
  • 最终用户分析
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球穿戴式註射器市场：按类型

  • 在身体上
  • 离开身体

第六章全球穿戴式註射器市场：依使用类型

  • 一次性的
  • 半一次性
  • 可重复使用的

第七章全球穿戴式註射器市场：依科技分类

  • 微流控系统
  • 电子系统
  • 混合系统
  • 机械系统
    • 气球储液器
    • 点滴帮浦
    • 振动系统
    • 旋转机构
    • 弹簧底座
  • 其他技术

第八章全球穿戴式註射器市场：依应用分类

  • 自体免疫疾病
  • 循环系统疾病
  • 糖尿病
  • 免疫力缺乏
  • 感染疾病
  • 肿瘤学
  • 其他用途

第九章全球穿戴式註射器市场：依最终用户分类

  • 医院
  • 诊所
  • 居家护理
  • 其他最终用户

第十章全球穿戴式註射器市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第十一章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十二章 公司简介

  • Amgen Inc.
  • Becton, Dickinson and Company
  • CeQur SA
  • Debiotech SA
  • E3D Elcam Drug Delivery Devices
  • Enable Injection Devices Ltd.
  • Insulet Corporation
  • Medtronic plc
  • Nemera Development SA
  • ScPharmaceuticals Inc.
  • Sensile Medical AG
  • SFC Fluidics
  • SteadyMed Therapeutics, Inc.
  • Tandem Diabetes Care, Inc.
  • Unilife Corporation
  • West Pharmaceutical Services, Inc.
  • Ypsomed Holding AG
Product Code: SMRC24662

According to Stratistics MRC, the Global Wearable Injectors Market is accounted for $9.01 billion in 2023 and is expected to reach $19.80 billion by 2030 growing at a CAGR of 11.9% during the forecast period. Wearable injectors are compact medical devices worn on the body, facilitating controlled and consistent drug delivery. These devices administer medication subcutaneously, offering convenience and precise dosing for patients with chronic conditions. They come in various forms, often incorporating electronic or mechanical systems, allowing for personalized treatment plans and enabling continuous or intermittent delivery of medications over extended periods.

According to the International Diabetes Federation, over 780 million people are expected to be living with diabetes, by 2045.

Market Dynamics:

Driver:

Increasing incidence of chronic illnesses

With an increasing prevalence of conditions like diabetes, cardiovascular diseases and autoimmune disorders, there's a growing demand for convenient and precise drug delivery methods. Wearable injectors offer a solution by providing patients with a means to self-administer medications, ensuring consistent dosing and improving treatment adherence. Their ability to accommodate long-term therapy for chronic conditions aligns with the need for enhanced patient convenience and efficient management of these ongoing health challenges, propelling their market growth.

Restraint:

Expenses associated with wearable injectors

The cost factor linked to wearable injectors poses a notable restraint in the market. These devices often entail high expenses due to their sophisticated technology, manufacturing intricacies, and specialized materials. This elevated cost can limit accessibility for some patients, impacting widespread adoption. Additionally, reimbursement challenges and healthcare budget constraints further impede their widespread use.

Opportunity:

Rising healthcare infrastructure and lifestyle disorders

As healthcare systems advance, there's increased emphasis on patient-centric care and innovative drug delivery methods. Wearable injectors align with this trend by offering a user-friendly, self-administered approach for managing chronic conditions prevalent in modern lifestyles. This convergence creates an opportunity for wearable injectors to address the needs of individuals with chronic illnesses, providing efficient and convenient drug delivery solutions, thereby fostering their adoption and market growth.

Threat:

Inclination towards alternative drug delivery systems 

While patients and healthcare providers explore diverse options like oral medications or traditional injections, the inclination away from wearable injectors challenges market growth. Factors such as patient preferences, cost considerations, and the development of competing technologies divert attention from wearable injector adoption. This trend might hinder the widespread acceptance of wearable injectors, impacting their market penetration and slowing the anticipated market expansion despite their advantages in precise and convenient drug delivery.

COVID-19 Impact:

The COVID-19 pandemic significantly influenced the wearable injectors market. Delayed elective procedures, reduced patient consultations and financial constraints led to a temporary slowdown in wearable injector adoption. However, the pandemic highlighted the need for remote healthcare solutions, potentially fostering long-term interest and innovation in wearable injectors as patients seek convenient, at-home treatment options amid healthcare disruptions.

The diabetes segment is expected to be the largest during the forecast period

The diabetes segment is poised to lead the wearable injectors market. With the escalating prevalence of diabetes worldwide, there's a growing demand for efficient and convenient drug delivery systems. Wearable injectors offer diabetic patients a way to manage insulin delivery conveniently, ensuring precise dosing and enhancing treatment adherence. Moreover, technological advancements and the development of user-friendly, integrated systems tailored for diabetes management further contribute to the dominance of this segment in the market.

The off-body injectors segment is expected to have the highest CAGR during the forecast period

The off-body injectors segment is set for substantial growth due to the device's portability and flexibility, allowing users to carry and administer medications conveniently without the constraints of being attached to the body. The trend towards more discreet and user-friendly drug delivery methods, especially for treatments requiring intermittent dosing or long-term therapies, drives the demand for off-body injectors. Additionally, their compatibility with various medications and their ability to accommodate diverse patient preferences contribute to their expansion within the wearable injectors market.

Region with largest share:

North America is expected to dominate the wearable injectors market due to a combination of advanced healthcare infrastructure, a high prevalence of chronic diseases and a tech-savvy population. The region's robust regulatory environment supports the adoption of innovative medical technologies. Rising healthcare expenditures and a strong presence of key market players further contribute to North America's leadership.

Region with highest CAGR:

Asia Pacific is positioned for significant growth in the wearable injectors market due to the region's expanding population, rising prevalence of chronic diseases and increasing healthcare awareness. Favorable government initiatives, improving healthcare infrastructure and the growing adoption of innovative technologies in countries like China, India, and Japan contribute to market expansion. Additionally, rising disposable incomes and a shift towards more patient-centric healthcare models in the region further propel the growth of wearable injectors in Asia Pacific.

Key players in the market:

Some of the key players in wearable injectors market include Amgen Inc., Becton, Dickinson and Company, CeQur SA, Debiotech SA, E3D Elcam Drug Delivery Devices, Enable Injection Devices Ltd., Insulet Corporation, Medtronic plc, Nemera Development SA, ScPharmaceuticals Inc., Sensile Medical AG, SFC Fluidics, SteadyMed Therapeutics, Inc., Tandem Diabetes Care, Inc., Unilife Corporation, West Pharmaceutical Services, Inc. and Ypsomed Holding AG.

Key Developments:

In May 2023, Enable Injections, Inc. collaborated with Viridian Therapeutics, Inc., a U.S.-based biotechnology company.

In January 2023, Tandem Diabetes Care, Inc. announced the acquisition of AMF Medical SA, manufacturer of Sigi Patch Pump.

In June 2022, AbbVie received US FDA approval for SKYRIZI (risankizumab-rzaa) as the first and only specific interleukin-23 (IL-23) inhibitor for the treatment of adults with moderately to severely active Crohn's disease (CD). It can be self-administered by Subcutaneous Injection (SC) with an On-Body Injector (OBI).

Types Covered:

  • On-body
  • Off-body

Usage Types Covered:

  • Disposable
  • Semi-Disposable
  • Reusable

Technologies Covered:

  • Microfluidic Systems
  • Electronic Systems
  • Hybrid Systems
  • Mechanical Systems
  • Other Technologies

Applications Covered:

  • Autoimmune Disease
  • Cardiovascular Disease
  • Diabetes
  • Immunodeficiency
  • Infectious Disease
  • Oncology
  • Other Applications

End Users Covered:

  • Hospitals
  • Clinics
  • Home Care
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Technology Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Wearable Injectors Market, By Type

  • 5.1 Introduction
  • 5.2 On-body
  • 5.3 Off-body

6 Global Wearable Injectors Market, By Usage Type

  • 6.1 Introduction
  • 6.2 Disposable
  • 6.3 Semi-Disposable
  • 6.4 Reusable

7 Global Wearable Injectors Market, By Technology

  • 7.1 Introduction
  • 7.2 Microfluidic Systems
  • 7.3 Electronic Systems
  • 7.4 Hybrid Systems
  • 7.5 Mechanical Systems
    • 7.5.1 Balloon Reservoir
    • 7.5.2 Infuser Pump
    • 7.5.3 Oscillatory Systems
    • 7.5.4 Rotary Mechanisms
    • 7.5.5 Spring-Based
  • 7.6 Other Technologies

8 Global Wearable Injectors Market, By Application

  • 8.1 Introduction
  • 8.2 Autoimmune Disease
  • 8.3 Cardiovascular Disease
  • 8.4 Diabetes
  • 8.5 Immunodeficiency
  • 8.6 Infectious Disease
  • 8.7 Oncology
  • 8.8 Other Applications

9 Global Wearable Injectors Market, By End User

  • 9.1 Introduction
  • 9.2 Hospitals
  • 9.3 Clinics
  • 9.4 Home Care
  • 9.5 Other End Users

10 Global Wearable Injectors Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Amgen Inc.
  • 12.2 Becton, Dickinson and Company
  • 12.3 CeQur SA
  • 12.4 Debiotech SA
  • 12.5 E3D Elcam Drug Delivery Devices
  • 12.6 Enable Injection Devices Ltd.
  • 12.7 Insulet Corporation
  • 12.8 Medtronic plc
  • 12.9 Nemera Development SA
  • 12.10 ScPharmaceuticals Inc.
  • 12.11 Sensile Medical AG
  • 12.12 SFC Fluidics
  • 12.13 SteadyMed Therapeutics, Inc.
  • 12.14 Tandem Diabetes Care, Inc.
  • 12.15 Unilife Corporation
  • 12.16 West Pharmaceutical Services, Inc.
  • 12.17 Ypsomed Holding AG

List of Tables

  • Table 1 Global Wearable Injectors Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Wearable Injectors Market Outlook, By Type (2021-2030) ($MN)
  • Table 3 Global Wearable Injectors Market Outlook, By On-body (2021-2030) ($MN)
  • Table 4 Global Wearable Injectors Market Outlook, By Off-body (2021-2030) ($MN)
  • Table 5 Global Wearable Injectors Market Outlook, By Usage Type (2021-2030) ($MN)
  • Table 6 Global Wearable Injectors Market Outlook, By Disposable (2021-2030) ($MN)
  • Table 7 Global Wearable Injectors Market Outlook, By Semi-Disposable (2021-2030) ($MN)
  • Table 8 Global Wearable Injectors Market Outlook, By Reusable (2021-2030) ($MN)
  • Table 9 Global Wearable Injectors Market Outlook, By Technology (2021-2030) ($MN)
  • Table 10 Global Wearable Injectors Market Outlook, By Microfluidic Systems (2021-2030) ($MN)
  • Table 11 Global Wearable Injectors Market Outlook, By Electronic Systems (2021-2030) ($MN)
  • Table 12 Global Wearable Injectors Market Outlook, By Hybrid Systems (2021-2030) ($MN)
  • Table 13 Global Wearable Injectors Market Outlook, By Mechanical Systems (2021-2030) ($MN)
  • Table 14 Global Wearable Injectors Market Outlook, By Balloon Reservoir (2021-2030) ($MN)
  • Table 15 Global Wearable Injectors Market Outlook, By Infuser Pump (2021-2030) ($MN)
  • Table 16 Global Wearable Injectors Market Outlook, By Oscillatory Systems (2021-2030) ($MN)
  • Table 17 Global Wearable Injectors Market Outlook, By Rotary Mechanisms (2021-2030) ($MN)
  • Table 18 Global Wearable Injectors Market Outlook, By Spring-Based (2021-2030) ($MN)
  • Table 19 Global Wearable Injectors Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 20 Global Wearable Injectors Market Outlook, By Application (2021-2030) ($MN)
  • Table 21 Global Wearable Injectors Market Outlook, By Autoimmune Disease (2021-2030) ($MN)
  • Table 22 Global Wearable Injectors Market Outlook, By Cardiovascular Disease (2021-2030) ($MN)
  • Table 23 Global Wearable Injectors Market Outlook, By Diabetes (2021-2030) ($MN)
  • Table 24 Global Wearable Injectors Market Outlook, By Immunodeficiency (2021-2030) ($MN)
  • Table 25 Global Wearable Injectors Market Outlook, By Infectious Disease (2021-2030) ($MN)
  • Table 26 Global Wearable Injectors Market Outlook, By Oncology (2021-2030) ($MN)
  • Table 27 Global Wearable Injectors Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 28 Global Wearable Injectors Market Outlook, By End User (2021-2030) ($MN)
  • Table 29 Global Wearable Injectors Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 30 Global Wearable Injectors Market Outlook, By Clinics (2021-2030) ($MN)
  • Table 31 Global Wearable Injectors Market Outlook, By Home Care (2021-2030) ($MN)
  • Table 32 Global Wearable Injectors Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.